Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor

Jeffrey L. Browning (Inventor), Jenny P-Y Ting (Inventor)

Research output: ResearchPatent

Abstract

Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.
LanguageEnglish
Patent number8067375
IPCA61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101)
StatePublished - 1800

Fingerprint

Lymphotoxin beta Receptor
Lymphotoxin-alpha
Demyelinating Diseases

Cite this

Browning, J. L., & Ting, J. P-Y. (1800). IPC No. A61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101). Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor (Patent No. 8067375.)

Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor. / Browning, Jeffrey L. (Inventor); Ting, Jenny P-Y (Inventor).

IPC No.: A61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101). Patent No.: 8067375.

Research output: ResearchPatent

Browning, JL & Ting, JP-Y 1800, Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor, Patent No. 8067375, IPC No. A61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101).
Browning JL, Ting JP-Y, inventors. Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor. A61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101). 1800
Browning, Jeffrey L. (Inventor) ; Ting, Jenny P-Y (Inventor). / Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor. IPC No.: A61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101). Patent No.: 8067375.
@misc{4b15b55a1f8f46e1bcd9152c9e2a1182,
title = "Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor",
abstract = "Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.",
author = "Browning, {Jeffrey L.} and Ting, {Jenny P-Y}",
note = "Status: published applicationnumber: 12/446,041 usclass: 514/19.2 ; 514/1.1; 530/351 applicationnumber: 12/446,041; 8067375; A61K 38/00 (20060101); C07K 1/00 (20060101); C07K 14/00 (20060101); C07K 17/00 (20060101); A61P 35/00 (20060101)",
year = "1800",
type = "Patent",

}

TY - PAT

T1 - Treatment of Demyelinating Disorders with Soluble Lymphotoxin-Beta-Receptor

AU - Browning,Jeffrey L.

AU - Ting,Jenny P-Y

N1 - Status: published applicationnumber: 12/446,041 usclass: 514/19.2 ; 514/1.1; 530/351 applicationnumber: 12/446,041

PY - 1800

Y1 - 1800

N2 - Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.

AB - Methods of treating a demyelinating disorder using inhibitors of the lymphotoxin pathway.

M3 - Patent

M1 - 8067375

ER -